A step-by-step guide on safely using vitamin D supplements to potentially boost breast cancer chemotherapy success, including consultation, testing, dosing, and monitoring.
Learn how MIT scientists transformed chaotic laser light into a focused pencil beam for 3D brain imaging, enabling 25x faster blood-brain barrier visualization.
Rivian posts Q1 revenue jump, delivers 10,365 vehicles (+20% YoY) as R2 production starts, reaffirms 62-67k full-year forecast. Path to profitability seen.
Rivian Q1 2026 earnings: revenue up, R2 production begins, sales jump 20%, production up 30%. Full-year forecast holds at 62-67k vehicles.
The 2026 Match set records but sparked false claims about IMGs taking spots. Data shows USMGs dominate, IMGs fill critical gaps, and collaboration beats restriction.
Eight key takeaways from the RFK Jr. congressional hearings, including NIH funding debates, bipartisan pushback on cuts, and voter demand for vaccine access.
A new tool predicts risk of 18 obesity complications using BMI, family history, diet, illness, and socioeconomic factors, aiming to guide GLP-1 drug prescriptions.
Akeso's ivonescimab earns ASCO plenary spot for lung cancer survival data, sparking speculation. This listicle covers 10 key insights including drug mechanism, trial design, regulatory impact, and market implications.
10 critical facts about wildfire smog's rising harm: health risks, vulnerable groups, climate links, long-distance spread, and actionable steps to stay safe.
A listicle breaking down Senate Minority Leader Chuck Schumer's health care affordability principles, plus a podcast aside on prison diets, into seven key insights.
Cigna exits ACA individual markets by 2027: 369K members affected, strategic pivot to Evernorth & employer plans, underscores marketplace turmoil.
Explore 10 essential facts about Hinge's new FDA-cleared migraine device—from how it works and clinical efficacy to cost and who it's for. Learn why this wearable neurostimulator is a game-changer for acute migraine relief in a drug-free format.
The DOJ accuses Elevance Health of blocking a key executive's deposition in a major Medicare Advantage fraud case, highlighting legal standoffs, timing suspicions, and high financial stakes.
FDA proposes excluding semaglutide and tirzepatide from compounding lists, impacting Novo Nordisk and Eli Lilly. Key facts: no clinical need, 503B facilities affected, consumer choices limited.
Trump replaces Casey Means with Nicole Saphier for Surgeon General; 10 key facts about both candidates, the MAHA movement, and implications for health policy.
Biotech podcast reveals key insights: hair loss drug trials spark investor interest, AI streamlines clinical trials, Servier's smart acquisition of Day One, the business of hair loss, and nonprofit-style pharma's M&A strategy.
Katherine Szarama named acting FDA vaccine/biologics center director, replacing Vinay Prasad. Five key insights on CBER, her background, Prasad's departure, expected changes, and future of vaccine regulation.
A founder's step-by-step guide to building a healthcare startup, covering FDA approval, fundraising, and team motivation, based on BioticsAI CEO Robhy Bustami's experience.
BioticsAI CEO reveals how the startup secured FDA clearance and Series A funding by embedding compliance early, motivating the team through regulatory hurdles.
New report: 51% of U.S. employees cried at work in the past month, up 12 points. AI fears and lack of boundaries drive stress. Experts urge employer action.